Clinical Trials Directory

Trials / Unknown

UnknownNCT04047407

Suprathreshold Pressure Pain Stimulation in Fibromyalgia

Pain Response Characteristics to Different Doses of Suprathreshold Pressure Stimulation in Fibromyalgia Subjects

Status
Unknown
Phase
Study type
Observational
Enrollment
52 (actual)
Sponsor
University of Castilla-La Mancha · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the induced-pain characteristics after suprathreshold pressure stimulation at different intensities in fibromyalgia subjects, compared with healthy volunteers.

Detailed description

Fibromyalgia syndrome is a chronic painful, non-inflammatory rheumatic disease with a high negative impact on the quality of life, and is characterized by widespread pain, fatigue and generalised hyperalgesia on examination, symptoms that can be the consequence of central sensitization. Despite several methods have successfully addressed this increased responsiveness of nociceptive neurons in the central nervous system, there is a lack of consensus about how to systematically perform them and those that are more appropriated for different syndromes. Therefore, investigating appropriate simple methods to assess clinical manifestations of central sensitization is relevant in the assessment of fibromyalgia. The present study aims to investigate the pain response after suprathreshols pressure stimulation in fibromyalgia subjects compared with healthy volunteers.

Conditions

Interventions

TypeNameDescription
DEVICESuprathreshold pain stimulationSuprathreshold pain stimulation will be applied in the infraspinatus muscle (point equidistant between the midpoint of the spine of the scapula, the inferior angle of the scapula and the midpoint of the medial border of the scapula) with a pressure algometer (Force Ten ™, Wagner Instruments, USA). Four suprathreshold pressure stimulations (pressure pain threshold + 20%, +30%, +40% and +50%) will be made for 60 seconds, with a minimum rest of 5 minutes between each stimulation. The sequence of stimulation (ascending or descending) will be randomized.

Timeline

Start date
2019-06-03
Primary completion
2019-09-18
Completion
2019-09-18
First posted
2019-08-06
Last updated
2019-08-06

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04047407. Inclusion in this directory is not an endorsement.